nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—Opportunistic infection—Methylprednisolone—psoriatic arthritis	0.0442	0.0442	CcSEcCtD
Dolutegravir—Opportunistic infection—Dexamethasone—psoriatic arthritis	0.0402	0.0402	CcSEcCtD
Dolutegravir—Opportunistic infection—Betamethasone—psoriatic arthritis	0.0402	0.0402	CcSEcCtD
Dolutegravir—Neutropenia—Auranofin—psoriatic arthritis	0.0357	0.0357	CcSEcCtD
Dolutegravir—Opportunistic infection—Prednisone—psoriatic arthritis	0.035	0.035	CcSEcCtD
Dolutegravir—Opportunistic infection—Methotrexate—psoriatic arthritis	0.0293	0.0293	CcSEcCtD
Dolutegravir—Flatulence—Auranofin—psoriatic arthritis	0.0262	0.0262	CcSEcCtD
Dolutegravir—Inflammation—Methylprednisolone—psoriatic arthritis	0.0184	0.0184	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.0178	0.0178	CcSEcCtD
Dolutegravir—Abdominal pain—Auranofin—psoriatic arthritis	0.0172	0.0172	CcSEcCtD
Dolutegravir—Pruritus—Auranofin—psoriatic arthritis	0.0154	0.0154	CcSEcCtD
Dolutegravir—Diarrhoea—Auranofin—psoriatic arthritis	0.0149	0.0149	CcSEcCtD
Dolutegravir—Vomiting—Auranofin—psoriatic arthritis	0.0138	0.0138	CcSEcCtD
Dolutegravir—Rash—Auranofin—psoriatic arthritis	0.0137	0.0137	CcSEcCtD
Dolutegravir—Dermatitis—Auranofin—psoriatic arthritis	0.0137	0.0137	CcSEcCtD
Dolutegravir—Nausea—Auranofin—psoriatic arthritis	0.0129	0.0129	CcSEcCtD
Dolutegravir—Inflammation—Methotrexate—psoriatic arthritis	0.0121	0.0121	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.0114	0.0114	CcSEcCtD
Dolutegravir—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00916	0.00916	CcSEcCtD
Dolutegravir—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00916	0.00916	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00903	0.00903	CcSEcCtD
Dolutegravir—Neutropenia—Prednisone—psoriatic arthritis	0.00827	0.00827	CcSEcCtD
Dolutegravir—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00808	0.00808	CcSEcCtD
Dolutegravir—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00798	0.00798	CcSEcCtD
Dolutegravir—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00783	0.00783	CcSEcCtD
Dolutegravir—Vertigo—Prednisolone—psoriatic arthritis	0.00762	0.00762	CcSEcCtD
Dolutegravir—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00709	0.00709	CcSEcCtD
Dolutegravir—Vertigo—Triamcinolone—psoriatic arthritis	0.00701	0.00701	CcSEcCtD
Dolutegravir—Vertigo—Methylprednisolone—psoriatic arthritis	0.00699	0.00699	CcSEcCtD
Dolutegravir—Neutropenia—Methotrexate—psoriatic arthritis	0.00691	0.00691	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00658	0.00658	CcSEcCtD
Dolutegravir—Renal failure—Methotrexate—psoriatic arthritis	0.00648	0.00648	CcSEcCtD
Dolutegravir—Immune system disorder—Prednisone—psoriatic arthritis	0.0064	0.0064	CcSEcCtD
Dolutegravir—Vertigo—Dexamethasone—psoriatic arthritis	0.00636	0.00636	CcSEcCtD
Dolutegravir—Vertigo—Betamethasone—psoriatic arthritis	0.00636	0.00636	CcSEcCtD
Dolutegravir—Insomnia—Prednisolone—psoriatic arthritis	0.00626	0.00626	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00623	0.00623	CcSEcCtD
Dolutegravir—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00623	0.00623	CcSEcCtD
Dolutegravir—Mental disorder—Prednisone—psoriatic arthritis	0.0062	0.0062	CcSEcCtD
Dolutegravir—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00617	0.00617	CcSEcCtD
Dolutegravir—Hepatitis—Methotrexate—psoriatic arthritis	0.00592	0.00592	CcSEcCtD
Dolutegravir—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00584	0.00584	CcSEcCtD
Dolutegravir—Urethral disorder—Methotrexate—psoriatic arthritis	0.0058	0.0058	CcSEcCtD
Dolutegravir—Insomnia—Triamcinolone—psoriatic arthritis	0.00576	0.00576	CcSEcCtD
Dolutegravir—Insomnia—Methylprednisolone—psoriatic arthritis	0.00575	0.00575	CcSEcCtD
Dolutegravir—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00567	0.00567	CcSEcCtD
Dolutegravir—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00567	0.00567	CcSEcCtD
Dolutegravir—Vertigo—Prednisone—psoriatic arthritis	0.00554	0.00554	CcSEcCtD
Dolutegravir—Fatigue—Triamcinolone—psoriatic arthritis	0.00549	0.00549	CcSEcCtD
Dolutegravir—Fatigue—Methylprednisolone—psoriatic arthritis	0.00548	0.00548	CcSEcCtD
Dolutegravir—Immune system disorder—Methotrexate—psoriatic arthritis	0.00535	0.00535	CcSEcCtD
Dolutegravir—Insomnia—Betamethasone—psoriatic arthritis	0.00523	0.00523	CcSEcCtD
Dolutegravir—Insomnia—Dexamethasone—psoriatic arthritis	0.00523	0.00523	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00521	0.00521	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00519	0.00519	CcSEcCtD
Dolutegravir—Mental disorder—Methotrexate—psoriatic arthritis	0.00518	0.00518	CcSEcCtD
Dolutegravir—Hypersensitivity—Prednisolone—psoriatic arthritis	0.0051	0.0051	CcSEcCtD
Dolutegravir—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00502	0.00502	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00499	0.00499	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00499	0.00499	CcSEcCtD
Dolutegravir—Fatigue—Betamethasone—psoriatic arthritis	0.00498	0.00498	CcSEcCtD
Dolutegravir—Fatigue—Dexamethasone—psoriatic arthritis	0.00498	0.00498	CcSEcCtD
Dolutegravir—Nervous system disorder—Prednisone—psoriatic arthritis	0.00493	0.00493	CcSEcCtD
Dolutegravir—Skin disorder—Prednisone—psoriatic arthritis	0.00489	0.00489	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00472	0.00472	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00472	0.00472	CcSEcCtD
Dolutegravir—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00469	0.00469	CcSEcCtD
Dolutegravir—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00468	0.00468	CcSEcCtD
Dolutegravir—Vertigo—Methotrexate—psoriatic arthritis	0.00463	0.00463	CcSEcCtD
Dolutegravir—Dizziness—Prednisolone—psoriatic arthritis	0.00458	0.00458	CcSEcCtD
Dolutegravir—Asthenia—Triamcinolone—psoriatic arthritis	0.00457	0.00457	CcSEcCtD
Dolutegravir—Abdominal pain—Betamethasone—psoriatic arthritis	0.00457	0.00457	CcSEcCtD
Dolutegravir—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00457	0.00457	CcSEcCtD
Dolutegravir—Asthenia—Methylprednisolone—psoriatic arthritis	0.00456	0.00456	CcSEcCtD
Dolutegravir—Insomnia—Prednisone—psoriatic arthritis	0.00455	0.00455	CcSEcCtD
Dolutegravir—Pruritus—Triamcinolone—psoriatic arthritis	0.0045	0.0045	CcSEcCtD
Dolutegravir—Pruritus—Methylprednisolone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Dolutegravir—Rash—Prednisolone—psoriatic arthritis	0.00437	0.00437	CcSEcCtD
Dolutegravir—Dermatitis—Prednisolone—psoriatic arthritis	0.00436	0.00436	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00436	0.00436	CcSEcCtD
Dolutegravir—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00435	0.00435	CcSEcCtD
Dolutegravir—Fatigue—Prednisone—psoriatic arthritis	0.00434	0.00434	CcSEcCtD
Dolutegravir—Headache—Prednisolone—psoriatic arthritis	0.00434	0.00434	CcSEcCtD
Dolutegravir—Dizziness—Triamcinolone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Dolutegravir—Dizziness—Methylprednisolone—psoriatic arthritis	0.0042	0.0042	CcSEcCtD
Dolutegravir—Asthenia—Dexamethasone—psoriatic arthritis	0.00414	0.00414	CcSEcCtD
Dolutegravir—Asthenia—Betamethasone—psoriatic arthritis	0.00414	0.00414	CcSEcCtD
Dolutegravir—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00412	0.00412	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Dolutegravir—Nausea—Prednisolone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Dolutegravir—Pruritus—Dexamethasone—psoriatic arthritis	0.00409	0.00409	CcSEcCtD
Dolutegravir—Pruritus—Betamethasone—psoriatic arthritis	0.00409	0.00409	CcSEcCtD
Dolutegravir—Skin disorder—Methotrexate—psoriatic arthritis	0.00408	0.00408	CcSEcCtD
Dolutegravir—Vomiting—Triamcinolone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Dolutegravir—Vomiting—Methylprednisolone—psoriatic arthritis	0.00404	0.00404	CcSEcCtD
Dolutegravir—Rash—Triamcinolone—psoriatic arthritis	0.00401	0.00401	CcSEcCtD
Dolutegravir—Dermatitis—Triamcinolone—psoriatic arthritis	0.00401	0.00401	CcSEcCtD
Dolutegravir—Rash—Methylprednisolone—psoriatic arthritis	0.00401	0.00401	CcSEcCtD
Dolutegravir—Dermatitis—Methylprednisolone—psoriatic arthritis	0.004	0.004	CcSEcCtD
Dolutegravir—Headache—Triamcinolone—psoriatic arthritis	0.00399	0.00399	CcSEcCtD
Dolutegravir—Headache—Methylprednisolone—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Dolutegravir—Abdominal pain—Prednisone—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Dolutegravir—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00395	0.00395	CcSEcCtD
Dolutegravir—Diarrhoea—Betamethasone—psoriatic arthritis	0.00395	0.00395	CcSEcCtD
Dolutegravir—Dizziness—Dexamethasone—psoriatic arthritis	0.00382	0.00382	CcSEcCtD
Dolutegravir—Dizziness—Betamethasone—psoriatic arthritis	0.00382	0.00382	CcSEcCtD
Dolutegravir—Insomnia—Methotrexate—psoriatic arthritis	0.0038	0.0038	CcSEcCtD
Dolutegravir—Nausea—Triamcinolone—psoriatic arthritis	0.00378	0.00378	CcSEcCtD
Dolutegravir—Nausea—Methylprednisolone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Dolutegravir—Hypersensitivity—Prednisone—psoriatic arthritis	0.00371	0.00371	CcSEcCtD
Dolutegravir—Vomiting—Betamethasone—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Dolutegravir—Vomiting—Dexamethasone—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Dolutegravir—Rash—Dexamethasone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Dolutegravir—Rash—Betamethasone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Dolutegravir—Dermatitis—Dexamethasone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Dolutegravir—Dermatitis—Betamethasone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00363	0.00363	CcSEcCtD
Dolutegravir—Fatigue—Methotrexate—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Dolutegravir—Headache—Betamethasone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Dolutegravir—Headache—Dexamethasone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Dolutegravir—Asthenia—Prednisone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Dolutegravir—Pruritus—Prednisone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Dolutegravir—Diarrhoea—Prednisone—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Dolutegravir—Nausea—Dexamethasone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Dolutegravir—Nausea—Betamethasone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Dolutegravir—Dizziness—Prednisone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Dolutegravir—Abdominal pain—Methotrexate—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Dolutegravir—Vomiting—Prednisone—psoriatic arthritis	0.0032	0.0032	CcSEcCtD
Dolutegravir—Rash—Prednisone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Dolutegravir—Dermatitis—Prednisone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Dolutegravir—Headache—Prednisone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Dolutegravir—Hypersensitivity—Methotrexate—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Dolutegravir—Asthenia—Methotrexate—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Dolutegravir—Nausea—Prednisone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Dolutegravir—Pruritus—Methotrexate—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Dolutegravir—Diarrhoea—Methotrexate—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Dolutegravir—Dizziness—Methotrexate—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Dolutegravir—Vomiting—Methotrexate—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Dolutegravir—Rash—Methotrexate—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Dolutegravir—Dermatitis—Methotrexate—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Dolutegravir—Headache—Methotrexate—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Dolutegravir—Nausea—Methotrexate—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
